Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health and Wellness Organizations Award Crowley for Supporting Employees


Crowley provides award-winning health and wellness support for employees.

The 2019 Crowley team for the Heart Walk in Jacksonville, Fla.

These awards spotlight Crowley’s focus and commitment as an employer who makes the health and wellness of our team members and their families a key priority,

Crowley’s success helping employees achieve health and wellness has resulted in two new awards recognizing the company’s support for the wellbeing of its people in their careers and lives, as well as their families.

Crowley won the National Best and Brightest in Wellness Award from the National Association for Business Resources for the fifth straight year for the effectiveness of its wellness programs.

The 44 winning companies recognized for the spring and summer award period were evaluated by an assessment created and administered by SynBella, a leading wellness systems firm. Companies were reviewed based on factors such as outcomes, participation and incentives, benefits and programs, employee input, and culture and environment.

In addition, the First Coast Worksite Wellness Council recognized Crowley with its Platinum Award for creating a culture of health and wellness. Crowley won for the 11th consecutive year, including the fifth straight year at platinum, the award’s highest level. The council’s program recognizes companies in the Jacksonville, Fla., metropolitan area where Crowley is headquartered.

“These awards spotlight Crowley’s focus and commitment as an employer who makes the health and wellness of our team members and their families a key priority,” said Tiffanny King, Crowley’s vice president of people and culture. “The well-being of employees is vitally important as we continue to be a high performing company for our customers. Supporting people’s health and wellness also is crucial to Crowley as an employer of choice for people seeking meaningful careers.”

The awards reflect Crowley’s commitment to provide employees health evaluations and risk assessments, as well as an array of wellness and health tools and opportunities, including:

  • flu shots
  • health coaching programs
  • weight management tools
  • mental health resources
  • fitness programs and events
  • emotional well-being education, and gym reimbursement programs.


During the COVID-19 pandemic, Crowley has continued to support employees with health and safety guidance, mental health assistance, guidance and support for healthy lifestyles while working from home and employee participation in virtual fitness events, such as run-walks.

About Crowley

Jacksonville-based Crowley Holdings Inc., a holding company of the 128-year-old Crowley Maritime Corporation, is a privately held family- and employee-owned company that provides worldwide logistics, government, marine and energy solutions. Crowley operates with four business units. Crowley Logistics is a full-service end-to end supply chain and managed transportation division that also includes ocean liner cargo services utilizing some company-owned vessels. Crowley Shipping encompasses ownership, operations and management of conventional and dual-fuel LNG (liquefied natural gas) vessels, including tankers, container ships, multipurpose vessels, tugboats and barges; engineering, project management and naval architecture; and Crowley LNG, which provides LNG distribution, engineering and related services. Crowley Fuels provides petroleum transportation, distribution and sales primarily throughout Alaska. Crowley Solutions focuses on global government services and program management, government ship management, expeditionary logistics and government-oriented freight transportation services. Additional information about Crowley, its subsidiaries and business units may be found at http://www.crowley.com.

Share article on social media or email:

Sentien Biotechnologies-Led Team Awarded $2.4M Contract from the U.S. Department of Defense and the Medical Technology Enterprise Consortium


News Image

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, has been awarded a $2.4 million contract from the Medical Technology Enterprise Consortium (MTEC). The funds will be used to support the development of a potency assay for mesenchymal stromal cells (MSCs) in regenerative medicine products.

Sentien has partnered with RoosterBio, Inc., a developer of MSCs and bioprocess media, and GenCure, a cell therapy-focused contract development and manufacturing organization (CDMO). Together, this team will develop a potency assay framework using MSCs, spanning large-scale biomanufacturing, in vitro assay development and in vivo biomarker analytics.

The award was granted by the U.S. Army Medical Research & Development Command (USAMRDC) in collaboration with the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (DoD).

The Defense Health Agency has identified a need for quality management in the biomanufacturing of regenerative medicine-based products. For cell therapy products, the potency assay is the most robust quality metric, representing the biological ability of a product to effect a clinical outcome. Developing a potency assay is a complex challenge, requiring significant characterization of process parameters and quality attributes throughout the preclinical and clinical development stages.

This work will take an integrated, cross-functional approach to potency assay development. First, biomanufacturing process parameters and quality attributes will be evaluated during the expansion of MSCs derived from different tissue sources. Second, the resulting cell banks will be analyzed using Sentien’s ex-vivo bioreactor platform to assess the immunomodulatory effects of the MSCs and generate putative potency markers. Finally, the putative potency markers will be matched against clinical trial samples from subjects with systemic inflammatory conditions who have been treated with SBI-101, Sentien’s lead product.

SBI-101 is a combination biologic product, in which MSCs reside on the exterior of hollow fibers, while blood flows through the interior. The unique design of SBI-101 enables real-time sampling of both MSC-secreted factors (pharmacokinetics) and their effect on patient blood (pharmacodynamics), which will provide particular value for this project. The ultimate goal of the project is to develop a broadly applicable potency assay framework that members of the regenerative medicine community can leverage for their particular biomanufacturing process, product and indication of interest.

“Sentien is grateful to MTEC and the DoD for recognizing the potential impact of our proposal and awarding the funds to undertake this work. We have an opportunity to add real value to the regenerative medicine community by developing this potency assay framework which spans R&D, biomanufacturing and clinical translation,” said Chris Gemmiti, Senior Vice President of Operations at Sentien. “This award demonstrates external recognition of how our proprietary microreactor platform can offer unique insights into MSC biology. This is very timely as the interest in MSCs has been increasingly heightened in the context of COVID-19 trials,” said Rita Bárcia, Vice President of R&D at Sentien. “We are very excited to be partnering with RoosterBio and GenCure on this project,” added Sentien CEO, Brian Miller. “We believe this team of collaborators, with complementary technologies and skills, will together produce a valuable, widely applicable deliverable.”

“We are very much looking forward to this collaboration to provide our platform solutions and expertise in MSC manufacturing in support of this project,” said RoosterBio CEO, Margot Connor. “The development of a MSC potency assay framework is really the cornerstone of a successful regenerative medicine product thus we are grateful for the opportunity to contribute to this team effort.”

Becky Cap, Chief Operating Officer for GenCure, a subsidiary of BioBridge Global, commented, “GenCure values creative approaches to solving difficult problems, and the Sentien team has developed some highly innovative approaches to treatment with SBI-101. With this project, they are finding ways to leverage that innovation to address more fundamental questions about potency and the impact of tissue source on both potency and therapeutic benefit. We are honored to be part of this project.”

About Sentien Biotechnologies

Sentien Biotechnologies, Inc. is a privately-held, clinical-stage company developing novel ex-vivo cell therapy applications to treat conditions caused by systemic, immune-mediated inflammation. Sentien’s lead product, SBI-101, integrates allogeneic mesenchymal stromal cells (MSCs) within an extracorporeal, hollow-fiber device. By immobilizing MSCs within a blood-filtration device, SBI-101 enables controlled, dynamic, and sustained delivery of MSC-secreted factors to the patient’s blood, without the need for direct injection of the MSCs themselves.

SBI-101 has been evaluated in a Phase 1b/2a study in subjects with dialysis-requiring acute kidney injury (AKI-D). An initial readout from the study provides preliminary evidence of anti-inflammatory and wound healing effects consistent with the SBI-101 therapeutic hypothesis. Building on this data, SBI-101 is being investigated in COVID-19 patients suffering from severe systemic inflammation.

Sentien’s technology can be applied to additional systemic inflammatory indications in both acute and chronic diseases, focusing on complex conditions where single-factor agents have not been effective. For more information, please visit http://www.sentienbiotech.com.

About RoosterBio, Inc.

RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. http://www.roosterbio.com

About GenCure

GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global, is focused on enabling the development of cell-based therapies by providing access to source materials, cGMP biomanufacturing experience and clinical research support. Learn more at http://www.gencurebiomanufacturing.org.

About Medical Technology Enterprise Consortium

MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transactional Agreement with the U.S. Army Medical Research and Materiel Command. To find out more about MTEC, visit http://www.mtec-sc.org.

Theory Wellness Makes Recreational Cannabis History as First to Open in Maine


Theory Wellness Retail Wall

Theory Wellness Retail Wall

“Nick and I have always loved Maine and have a deep affinity for it—both personally and professionally. For Theory Wellness to join the repeal of cannabis prohibition among some of the finest cannabis cultivators in the world is a long-standing dream.”—Brandon Pollock, CEO, and Co-Founder

Theory Wellness, a craft cannabis company with roots in Massachusetts will be opening their first out-of-state recreational dispensary in South Portland, Maine on Friday, October 9th. Theory’s launch of the first store in Maine comes nearly two years after the company had begun the competitive application process.

On September 8th, Theory was awarded one of only two final recreational retail licenses issued in the entire state (a few more have since been issued). Their location, minutes from the Portland airport and I-95, will open its doors this Friday at 10 AM. Since their initial license was granted, they have subsequently received their production and cultivation licenses as well, making them one of two vertically integrated operators in the entire state. Their cultivation and production facilities will be located in Waterville, where the company’s leaders have strong ties.

Theory’s CEO, Brandon Pollock, and co-founder and CFO, Nick Friedman are Colby College graduates (and roommates) who started their first company in Waterville, a bottle-less water cooling system, Blue Water Reserve. “Nick and I have always loved Maine and have a deep affinity for it—both personally and professionally. For Theory Wellness to join the repeal of cannabis prohibition among some of the finest cannabis cultivators in the world is a long-standing dream. We’ve found success here [in Massachusetts] and hope to carry the same learnings to a new state.”

An early entrant in the Massachusetts recreational cannabis market, Theory will be one of the first dispensaries in Maine to sell legal, recreational cannabis to those who are 21 and older. The location at 198 Maine Mall Rd. provides ample parking just a few minutes from the airport and minutes off I-95. The Company anticipates this location will employ upwards of 20 people as operations get underway.

About Theory Wellness, Inc:

Theory Wellness, Inc. is a vertically integrated cannabis cultivation, retail, and product manufacturing company headquartered in Stoneham, MA. Theory operates multiple cultivations and retail locations in Massachusetts and Maine. All products are manufactured in their state-of-the-art facility and produced in small batches, which undergo thorough independent lab testing.

Share article on social media or email:

The Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai selects Agnite Health LLC as its Revenue Cycle Management Company


With Agnite’s help, we were able to reduce our accounts receivable by 34% and our oldest accounts (aged over 120 days) by almost 50% within the first 6 months of our partnership.

Michael Carroll, co-founder and CEO of Agnite Health LLC (Agnite) is pleased to announce a very successful outsourced billing partnership with the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai (NYEE). According to Mr. Carroll, “We are now several months into our engagement and NYEE has been very pleased with the overall results of Agnite’s performance.” Agnite currently provides a complete billing and collections service for NYEE. Agnite’s services are comprehensive in nature. Agnite handles everything from charge posting to working accounts receivable.

Salvatore Loiacono, Deputy Chair of Administration and Finance at New York Eye and Ear Infirmary of Mount Sinai shared, “With Agnite’s help, we were able to reduce our accounts receivable by 34% and our oldest accounts (aged over 120 days) by almost 50% within the first 6 months of our partnership. Managing our accounts receivable has been especially important with the financial challenges resulting from the Covid-19 pandemic, and Agnite has done an excellent job maximizing our cashflow to support the practice.”

About Agnite Health LLC

Agnite Health LLC is a cost-effective billing and collections company that is a complete solution for all subspecialties in ophthalmology. We specialize in private practices, ambulatory surgical centers, academic eye centers, hospitals, and optical billing for practices. In today’s economic environment as reimbursements continue to decline, many ophthalmologists, optometrists and management personnel rely on Agnite Health LLC as a trusted billing business partner. Agnite Health LLC is an affiliate of Advantage Administration, Inc.

About New York Eye and Ear Infirmary of Mt. Sinai

New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America’s first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.

Share article on social media or email:

United Breast Cancer Foundation Achieves GuideStar Platinum Rating


UBCF Achieves GuideStar Platinum Seal of Transparency

“This year UBCF celebrates 20 years of service. The GuideStar Platinum Seal is a testament to UBCF standing the test of time, adapting and changing through the climate of economic challenges and continued growth to provide support to the breast cancer community.” – Ms. Stephanie Mastroianni

United Breast Cancer Foundation (UBCF) is proud to announce that it recently earned the GuideStar 2020 Platinum Seal of Transparency, proving UBCF’s commitment to breast cancer clients and loyal donors. Navigating the nonprofit world can often be confusing with a lack of transparency. GuideStar is home to the largest source of information on nonprofit organizations and has 13 million visitors a year. GuideStar Platinum encourages nonprofit organizations to share their progress and program results in important new ways to reflect the changes organizations are making in the world.

UBCF President and Executive Director, Ms. Stephanie Mastroianni stated, “The GuideStar Platinum Seal of Transparency rating is validation of the two decades of hard work and dedication UBCF has provided to our clients and the communities we work in across the country. In the past five years, UBCF has serviced more than 21,000 women, men and children through our seven programs. Additionally, we’ve reached over 10 million people through our numerous education and awareness campaigns.” Mastroianni went on to say, “This year UBCF celebrates 20 years of service. The GuideStar Platinum Seal is a testament to UBCF standing the test of time, adapting and changing through the climate of economic challenges and continued growth to provide support to the breast cancer community.”

GuideStar provides Bronze, Silver, Gold, and Platinum seals to nonprofit organizations to help users better understand each organization’s commitment to achieving its mission. To achieve a Platinum seal, UBCF shared their complete story with the world including information about their mission, programs and results, financial data, operations, board leadership, and organizational demographics. To see UBCF’s metrics and progress over the years, visit UBCF’s GuideStar profile here.

UBCF is proud to be a source of transparency and a trusted charity for 20 years. UBCF thanks those who have offered their support along the way. Your gift to UBCF is truly making a difference in the lives of women, men and families managing breast cancer. Visit ubcf.org to make tax-deductible contribution today.

About UBCF

UBCF is committed to offering breast health and wellness services focused on cancer prevention, screening, treatment and overall wellness. UBCF’s mission is to make a positive difference in the lives of those affected by breast cancer and carries it out through seven life-supporting patient and family programs available to women, men and families nation-wide. UBCF never denies services to anyone regardless of age, race, gender, ethnicity, income or medical insurance coverage. Tax-deductible contributions may be made towards UBCF’s programs. UBCF accepts vehicle and property donations as well. Combined Federal Campaign #77934. https://www.ubcf.org

Share article on social media or email:

Aperture Credentialing rebrands as Aperture Health


Aperture Health

“At Aperture, we have built a strong brand and reputation as an industry leader for high quality, consistent delivery of credentialing services.”

Aperture Credentialing, the largest volume Credentials Verification Organization (CVO) in the U.S., announces a rebranding of the company to Aperture Health. Aperture has expanded product and services offerings well beyond credentialing and now brings a substantially broader suite of provider and network management solutions to payer, provider and government clients.

“At Aperture, we have built a strong brand and reputation as an industry leader for high quality, consistent delivery of credentialing services”, said Charlie Falcone, CEO of Aperture Health. “We are very excited to announce that we have expanded our services well beyond credentialing to include provider directories, provider data quality and network management. With our broader set of solutions, we felt we needed a new brand to reflect the Aperture of today. Aperture Health, as our new company name, retains the Aperture brand-recognition but broadens our focus beyond credentialing alone”.

Aperture has delivered and modernized credentialing and has been serving health plans, health systems and government entities for over 20 years. The newly expanded Aperture services are also proven, modern industry technologies and services – actively deployed in the healthcare market today and supporting small and large payers, exchanges, brokers, state Medicaid enrollment programs and state-wide directory initiatives.

“We are thrilled to bring this full suite of network and provider data management solutions together under Aperture Health”, said Kymberly Eide, President of Aperture. “These adjacent and complementary technologies and services, under one organization, allow us to truly make an impact and drive efficiencies into historically siloed functions in the healthcare market”.

About Aperture

Founded in 2002 and headquartered in Louisville, Kentucky, Aperture is the largest national provider of credentialing services to the healthcare industry and now also provides directory services. data quality programs and network management technologies to many payer, broker, exchange and state government clients. With its credentialing programs, Aperture manages more physicians, ancillary and mid-level clinicians than any other credentialing verification organization in the country and can handle all types of providers and provider networks. For provider search and directories, Aperture supports some of the most complex, largest tiered networks in healthcare. Aperture maintains strict regulatory compliance standards. The company is URAC CVO accredited and NCQA CVO and CR certified and the provider directory products are NCQA HIP4 certified. For more information, visit http://www.aperture.health.

Share article on social media or email:

MobilityWorks Announces $1 Rental of Wheelchair Accessible Vans to Help Customers Get to the Polls


With over 90 locations in 31 states, MobilityWorks has the ability to help increase voter participation and civic engagement. “Our focus has always been to enable people who use wheelchairs to go where they want to go and do what they want to do,” said Chris Paczak, Chief Marketing Officer at MobilityWorks. “We are proud to support our civic minded customers who have the ability to choose how they want to vote by removing transportation limitations”.

In addition to providing $1 rentals to their customers, MobilityWorks is also making it possible for civic minded employees to work the polls. “Each year we provide our team members with three paid social responsibility days that they can use to give back to their communities in a variety of meaningful ways”, said Jillian Montmarquet, Chief Human Resources Officer at MobilityWorks. “This year we are encouraging them to help their communities and volunteer at the polls”.

Over the last two decades, MobilityWorks has had passion and mission to provide affordable, reliable wheelchair accessible vehicles to everyone. The main objective of the organization is to find the best mobility solution for each individual to ensure they can connect with who and what matters most.

For details about the $1 rental of a wheelchair accessible van visit https://www.mobilityworks.com/wheelchair-vans-for-rent/.

MobilityWorks (aka WMK, LLC) is a Cleveland, Ohio-based Inc. 500 company that employs specially trained Certified Mobility Consultants to work closely with its clients to understand their specific transportation needs in finding the right vehicle solution. Founded in 1997 with one location, MobilityWorks has been recognized on the Inc. 500|5000 list of Inc. Magazine’s fastest growing privately held companies for the past fourteen years. MobilityWorks Commercial is the largest provider of commercial wheelchair vans in the country. Driverge is the manufacturing division of WMK, LLC and is Ford Motor Company’s largest mobility upfitter. Learn more about MobilityWorks at https://www.mobilityworks.com.

Share article on social media or email:

Modality Solutions Makes 2020 Houston Business Journal Fast 100 List Second Consecutive Year


Fast 100 2020

Modality Solutions made the Houston Business Journal’s 2020 Fast 100 rankings of the city’s fastest-growing privately held companies for the second consecutive year with 65% revenue growth.

Our mission is to help our clients successfully launch new therapies and assist them in preparing for regulatory reviews. And I’m proud to say our team is made up of the brightest engineering professionals in biopharmaceutical cold chain logistics,” said Hutchinson

Modality Solutions, a Houston-based biopharmaceutical cold chain validation engineering firm, is pleased to announce it made the Houston Business Journal’s 2020 Fast 100 rankings of the city’s fastest-growing privately held companies for the second consecutive year. Companies ranked by revenue growth from 2017 to 2019. The engineering firm moved up from No. 90 on the 2019 list to No. 62 on the 2020 list with 65 percent revenue growth.

“Amid the challenging business environment of COVID-19, the Houston Business Journal is proud to once again recognize the fastest-growing private companies in Houston,” said Bob Charlet, Publisher. HBJ announced in July the list of Fast 100 companies in alphabetical order, with the final rankings revealed during a live online broadcast September 18.

To qualify for the Fast 100, companies on the list must meet the following criteria:

  • Be headquartered in the Houston area.
  • Be for-profit and privately held.
  • Been in operation for at least five full fiscal years and have earned at least $1 million in revenue in the latest fiscal year.

Information for the Fast 100 list was obtained from questionnaires completed by company representatives and compiled by HBJ research.

Award-winning Modality Solutions also made the Inc. 5000 list two consecutive years. For 2020, it reported a three-year revenue growth of 71 percent. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment–its independent small businesses. Modality Solutions was one of four engineering firms from the metro area and one of 11 in the State of Texas.

Co-founded in 2011 by Gary Hutchinson and Daniel J. Littlefield, Modality Solutions is a global biopharmaceutical cold chain validation engineering firm. It supports fast-track regulatory approval for biologics and specialty therapies. As industry logistics network experts, it provides engineering services focused on the qualification of thermal packaging, the selection of monitoring & controls systems, the execution of transport validation, the design of controlled-environment logistics, and the operational support for clinical trials.

“Modality Solutions is pleased to be recognized for the second year in a row for our sustained managed growth in the Houston region,” said President Gary Hutchinson. “Our mission is to help our clients successfully launch new therapies and assist them in preparing for regulatory reviews. And I’m proud to say our team is made up of the brightest engineering professionals in biopharmaceutical cold chain logistics.”

To learn more about Modality Solutions, visit https://www.modality-solutions.com.

About Modality Solutions, LLC

Founded in 2011, Modality Solutions, a leading biopharmaceutical cold chain validation engineering firm, specializes in integrating cold chain operations, developing transport validation strategies, supporting global regulatory applications, and global clinical trial operations. By combining the best practices of process validation, systems qualification, and risk assessment, Modality Solutions has earned the reputation of ensuring regulatory compliance, drug product quality, and patient safety. As a 2019 and 2020 Inc. 5000 and Houston Business Journal Fast 100 company, Modality Solutions’ team of engineers are experts at delivering cold chain thermal packaging design and qualification, conducting transport simulation testing with its Advantage Transport Simulation Laboratory™, and designing controlled environment-logistics solutions. For more information, visit https://www.modality-solutions.com.

Share article on social media or email:

Interventional Pain Management Specialist Dr. Kaliq Chang with Atlantic Spine Center offers tips on emerging treatment using your body’s own cells


Dr. Kaliq Chang

With two decades of research largely supporting PRP’s benefits for conditions such as shoulder and knee pain, growing evidence suggests the minimally invasive treatment can also safely improve highly common lower back pain.

Among the wide array of treatments available for chronic back pain, one is emerging that’s distinct because it uses your body’s own cells to help you heal. It’s called PRP, or platelet-rich plasma.

With two decades of research largely supporting PRP’s benefits for conditions such as shoulder and knee pain, growing evidence suggests the minimally invasive treatment can also safely improve highly common lower back pain, says Kaliq Chang, MD, of Atlantic Spine Center.

PRP Platelet-rich plasma treatment involves taking a small sample of your blood and placing it in a machine called a centrifuge, which separates blood components. The plasma, or liquid, part of your blood is then placed in a syringe and injected into the painful area of your back while a special x-ray helps pinpoint where it’s needed most, Dr. Chang explains.

Within weeks, PRP treatment often results in significantly less back pain and a greater ability to perform everyday activities, he says.

“More and more patients with lingering low back pain are inquiring about PRP to help rid them of the problem,” adds Dr. Chang, an interventional pain management specialist. “While additional data is still needed, it’s great to be able to tell them that PRP is becoming yet another sturdy tool in our arsenal of treatments to help beat back pain.”

How does PRP work?

Blood contains many substances that help promote the body’s healing process, and PRP treatment was developed on this premise, Dr. Chang says. As the so-called “building blocks” of blood, platelets – which also help form scabs on abrasions, for example – contain chemicals known as growth factors that support healing.

Also in platelets are proteins that trigger stem cells – which can change into any type of cell – to move toward an injured area. Growth factors and proteins work together to repair damaged tissue and make new, healthy tissue, Dr. Chang explains.

“While our bodies normally carry out wound healing naturally, PRP injections concentrate those restorative cells at just the place we need them and in larger amounts,” he says. “In the lower back, this means damaged areas around the spine receive a much-needed boost to speed healing.”

Back conditions PRP can help

PRP isn’t ideal for all types of low back pain, but your doctor – after a thorough exam and workup – may decide it’s a worthy option. What types of back problems can PRP treatment benefit? Pain caused by:

Degenerative disc disease, which are worn-down vertebral discs

Muscle strains

Damaged ligaments and tendons

Muscle fibrosis

Two or three PRP treatments spaced over several months are optimal and seem to improve pain and function in the lower back more than a single treatment, Dr. Chang notes.

After an injection, you can expect to have some mild soreness near the injection site that lasts for a few days. Since PRP works by stimulating your natural healing response, it generally takes a few weeks before you start seeing the benefits. Because PRP is derived from your own blood, you cannot reject the cells – a clear advantage, Dr. Chang says.

PRP treatments may also be combined with other approaches, such as physical therapy, to maximize the feel-good effects.

“Mounting research suggests PRP is a safe, fast and powerful way to help facilitate healing in a hardworking area of our body – the lower back,” Dr. Chang says. “We’re happy to have a new and exciting way to help patients get back to their everyday activities with less pain and more joy.”

Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC. http://www.atlanticspinecenter.com, http://www.atlanticspinecenter.nyc

Kaliq Chang, MD, is an interventional pain management specialist, double board-certified in interventional pain management and anesthesiology, at Atlantic Spine Center.

Share article on social media or email:

Harnessing “The Power of Omics” with Thermo Fisher Scientific’s Virtual Conference, October 13-15, 2020


Harnessing “The Power of Omics” with Thermo Fisher Scientific’s Virtual Conference, October 13-15, 2020.

The Thermo Fisher Power of Omics conference is being held virtually October 13–15, 2020, on the LabRoots platform. The event is for those with an interest in any of the “omics” fields, including, but not limited to, genomics, transcriptomics, proteomics and metabolomics.

The conference will feature a series of presentations, from academia and industry-leading experts. Areas of study will include:

  • Virion proteomics, structural analysis, protein interactomics and host-cell interactions and how these areas of research drive the development of vaccines and diagnostics.
  • Cancer pathway proteomics, proteogenomics, and immunopeptidomics as well as examples of standardization across laboratories.


The conference will also showcase several collaborations (including single-cell proteomics, native MS for structural analysis, multiplexed proteomics and artificial intelligence) that enable the mass analysis of proteins from any organism significantly faster than before, and almost error-free.

Roundtable discussions will focus on challenges of delivering fast but quality science, what’s needed to accelerate discovery research through practical utility, and standards that will deliver the promise of proteomics for human health. In addition to the presentations, audiences can visit our five virtual booths, where Thermo Fisher Scientific experts will answer any questions you may have. There will also be a dedicated poster hall and a networking lounge for conversing with other participants.

Produced on LabRoots’ robust platform, connecting across all desktop and mobile devices, the interactive experience will allow participants in the Power of Omics conference to accumulate points for a chance to win prizes. To register for the event, click here.

About Thermo Fisher Scientific

Thermo Fisher Scientific’s mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivalled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

About LabRoots

LabRoots is the leading scientific social networking website, as well as a primary source for scientific trending news, premier educational virtual events/webinars and more. Contributing to the advancement of science through content-sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining Continuing Education Credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email: